Protective Effects of Silymarin Against D-Gal/LPS-Induced Organ Damage and Inflammation in Mice
Xin Zhao,Haoxiang Wang,Yue Yang,Yuting Gou,Zhiying Wang,Dingyi Yang,Chong Li
DOI: https://doi.org/10.2147/DDDT.S305033
2021-05-05
Abstract:Xin Zhao, 1– 3, * Haoxiang Wang, 4, * Yue Yang, 1, 5 Yuting Gou, 1, 5 Zhiying Wang, 6 Dingyi Yang, 7 Chong Li 1– 3 1 Chongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, 400067, People's Republic of China; 2 Chongqing Engineering Research Center of Functional Food, Chongqing University of Education, Chongqing, 400067, People's Republic of China; 3 Chongqing Engineering Laboratory for Research and Development of Functional Food, Chongqing University of Education, Chongqing, 400067, People's Republic of China; 4 Department of Neurology, Second Affiliated Hospital of Army Medical University, Chongqing, 400037, People's Republic of China; 5 College of Biological and Chemical Engineering, Chongqing University of Education, Chongqing, 400067, People's Republic of China; 6 School of Pharmacy, Heilongjiang University of Traditional Chinese Medicine, Harbin, 150040, People's Republic of China; 7 Key Laboratory for Biorheological Science and Technology of Ministry of Education (Chongqing University), Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, 400044, People's Republic of China *These authors contributed equally to this work Correspondence: Chong Li; Dingyi Yang Tel +86-23-6265-3650 Email ; Aim: Silymarin contains various flavonoids and exhibits antioxidative, anti-inflammatory, and anticancer effects, in addition to other pharmacological properties. This study explored the alleviating effect of silymarin on multiple-organ damage induced by D-galactose/lipopolysaccharide in Kunming mice. Methods: Kunming mice were injected intraperitoneally with D-galactose (30 mg/kg·BW)/LPS (3 μg/kg·BW) and then treated using silymarin with different doses (75 mg/kg·bw and 150 mg/kg·bw) via intragastric administration. Changes in organ indexes, pathological changes, liver-function index, biochemical indexes, molecular biological indexes, and genes related to the oxidation and inflammation of main organs were evaluated. Results: After the mice were treated with silymarin, their body weight showed no significant change, and the liver, kidney, and lung indexes of the treated mice were higher than those of the model group; meanwhile, the corresponding histopathological formation was reduced. Compared with the model group, the silymarin-treated group showed reductions in ALT, AST, and liver function indexes in the mouse serum. Silymarin treatment also increased the SOD, CAT, GSH, GSH-Px, T-AOC, IL-10, and IL-12 levels, as well as reduced the MDA, NO, IL-6, IL-1β, TNF-α, IFN-γ levels in the mouse serum and liver tissues. In addition, quantitative polymerase chain reaction analysis indicated that the mRNA expression levels of SOD1, SOD2, CAT, GSH-Px, IL-10, Nrf2, HO-1, NQO1, Trx , and IκB-α were higher in the liver tissue of the silymarin-treated mice than in those of the model group; meanwhile, the mRNA expression levels of IL-6, IL-1β, TNF-α, IFN-γ, NF-κB, NLRP3, COX2 , and p38 were lower than those in the model group. Conclusion: Silymarin, which exhibits antioxidative and anti-inflammatory effects, can alleviate the liver, lung, and kidney damage induced by D-galactose/lipopolysaccharide. High-dose (150 mg/kg·bw) silymarin can more effectively inhibit organ damage, compared with low-dose silymarin (75 mg/kg·bw) in Kunming mice. Keywords: silymarin, organ injury, D-galactose/lipopolysaccharide, antioxidation, anti-inflammation Sepsis is a clinical syndrome, with infection as the pathological basis and inflammatory response as the basic pathological change. It can often cause damage to multiple systems and multiple organs and ultimately lead to multiple-organ failure. The course of inflammation in patients usually ranges from inflammatory reactions to sepsis, severe sepsis, septic shock, and multiple-organ failure. Owing to relatively weak immunity, infants and the elderly are more likely to induce sepsis and sepsis-related deaths than other patient groups. 1 The mechanisms underlying sepsis and secondary organ injury (liver, lung, kidneys, and other important organs) leading to death and inflammation have yet to be determined. Liver injury can also induce and aggravate injury to other organs. The reason is that the liver has important functions, such as detoxification and immunity. Currently, the main mechanisms of sepsis-induced liver injury include microcirculation disturbance, energy metabolism disturbance of hepatocytes, dysfunction of hepatocytes and liver, effects of end -Abstract Truncated-